Kerry Group plc

KRZ

IE0004906560

Food Processing

Market Closed - Irish S.E. Other stock markets 11:55:00 2024-04-26 am EDT			5-day change	1st Jan Change
80.15 ^EUR	+0.94%		+0.94%	+1.89%

Apr. 02	Bernstein starts AstraZeneca at 'outperform'	AN
Feb. 22	Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM

Tranche Update on Kerry Group plc's Equity Buyback Plan announced on November 1, 2023.

February 15, 2024 at 02:00 am EST

From November 1, 2023 to January 31, 2024, the company has repurchased 2,122,342 shares, representing 1.2% for £160.6 million. With this, the company has completed the repurchase of 2,122,342 shares, representing 1.2% for £160.6 million under the buyback announced on November 1, 2023.

Latest news about Kerry Group plc

Bernstein starts AstraZeneca at 'outperform'	Apr. 02	AN
Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM	Feb. 22
KERRY GROUP : Outlook somewhat disappointing	Feb. 19
FTSE 100 Closes Up As Investors Shrug Off Recession Confirmation	Feb. 15	DJ
Kerry Group plans new share buyback after 20% profit rise in 2023	Feb. 15	AN
US Futures, European Stocks Rise	Feb. 15	DJ
Kerry Group Pretax Profit Rose; Plans Further Share Buyback	Feb. 15	DJ
Kerry Group Posts Higher FY23 Profit, Revenue Declines	Feb. 15	MT
Kerry Group Seeks M&A Investment Opportunities	Feb. 15	CI
Transcript : Kerry Group plc, Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Earnings Flash (KYGA.L) KERRY GROUP Posts Fiscal H1 Revenue EUR8.02B	Feb. 15	MT
Earnings Flash (KYGA.L) KERRY GROUP Posts Fiscal H1 EPS EUR4.10	Feb. 15	MT
Tranche Update on Kerry Group plc's Equity Buyback Plan announced on November 1, 2023.	Feb. 15	CI
Kerry Group plc Proposes A Final Dividend, Payable on 10 May 2024	Feb. 15	CI
Kerry Group plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals	Jan. 26	MT
KERRY GROUP : Opinion change, from Buy to Add	Jan. 03
Celadon Pharma raises GBP2.0 million via placing	Dec. 12	AN
Novozymes-Chr. Hansen Merger Gets EU Nod After Proposed Asset Sale	Dec. 12	MT
Kerry Group Buys Novozymes, Chr. Hansen Assets for EUR150 Million	Dec. 12	DJ
Kerry Group to buy lactase business for EUR150 million	Dec. 12	AN
JPMorgan raises Rio Tinto to 'overweight'	Dec. 12	AN
Kerry Group plc agreed to acquire Lactase enzyme business from Chr. Hansen Holding A/S and Novozymes A/S (CPSE:NZYM B) for ?150 million.	Dec. 11	CI
Kerry Group plc Announces the Appointment of Msliz Hewitt as Non-Executive Director and as Member of the Audit Committee, with Effect from 1 March 2024	Dec. 11	CI
Kerry says share buyback programme to run until end of April	Nov. 01	AN

Chart Kerry Group plc

Duration

Period

More charts

Company Profile

Kerry Group plc is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. It innovates with its customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Net sales break down by family of products as follows: - tastes and nutritional ingredients (86.5%); - dairy ingredients and products (13.5%; Dairy Ireland): primarily functional proteins, nutritional bases and chilled dairy. At the end of 2023, the group had 137 production sites worldwide. Net sales are distributed geographically as follows: Ireland (6.7%), Europe (24.7%), Americas (47.4%) and Asia/Pacific/Middle East/Africa (21.1%).

Sector

Food Processing

Calendar

2024-05-02 - Q1 2024 Sales and Revenue Release - Interim Management Statement

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

KERRY GROUP : Outlook somewhat disappointing

February 19, 2024 at 02:32 am EST

Kerry Group plc : A champion of functional ingredients

September 25, 2023 at 06:02 am EDT

More Strategies

Ratings for Kerry Group plc

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

80.15 EUR

Average target price

96.59 EUR

Spread / Average Target

+20.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Food Processing

	1st Jan change	Capi.
KERRY GROUP PLC	+1.89%	14.85B
NESTLÉ S.A.	-4.93%	266B
MONDELEZ INTERNATIONAL, INC.	-2.51%	94.98B
KRAFT HEINZ	+3.19%	46.39B
GENERAL MILLS, INC.	+8.74%	39.99B
DANONE	-0.65%	39.95B
THE HERSHEY COMPANY	-0.15%	38.02B
ARCHER-DANIELS-MIDLAND COMPANY	-16.78%	30.16B
NESTLÉ INDIA LIMITED	-6.61%	28.72B
ASSOCIATED BRITISH FOODS PLC	+11.32%	24.54B

Other Food Processing

Kerry Group plc

Equities

KRZ

IE0004906560

Food Processing

Tranche Update on Kerry Group plc's Equity Buyback Plan announced on November 1, 2023.

EPS Revisions

Quarterly revenue - Rate of surprise